For citations:
Borzova M.A. Real-world data: general regulatory approaches in the EU and Japan. Real-World Data & Evidence. 2022;2(1):11-16. https://doi.org/10.37489/2782-3784-myrwd-7
Views: 97
Fullscreen
Popular articles
Vol 1, No 1 (2021)
Vol 1, No 1 (2021)
Vol 1, No 1 (2021)
Vol 2, No 1 (2022)
Vol 1, No 1 (2021)
Article Tools
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)
About the Author
Keywords
COVID-19
Chinese experience
Eurasian Economic Union
R
RWD
RWE
Russia
clinical registries
drug interactions
drug safety
favipiravir
international experience
medicinal plant
medicinal plant materials
molnupiravir
observation programs
pharmacovigilance
real-world data
real-world evidence
regulatory approaches
umifenovir
